RLY5016: Phase IIb data

The double-blind, international Phase IIb PEARL-HF trial in 104 patients already receiving >=1 renin-angiotensin-aldosterone system (RAAS)

Read the full 169 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE